Overall Survival Prediction of Docetaxel-based Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Overall Survival Prediction of Docetaxel-based Second-line Treatment for Advanced Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis

Objectives: Non-small cell lung cancer (NSCLC) accounts for 75–85% of all lung cancer diagnoses. This meta-analysis sought to estimate the overall survival (OS) of NSCLC based on randomized control trials which had compared docetaxel with kinase inhibitors, antineoplastic agents, and monoclonal anti...

Full description

Bibliographic Details
Main Authors: Chaitra Nagaraju, Gayatri Vaidya, Anisha S. Jain, Amrutha Puthiyidath Nair, Sahana Chandrappa, Chandrashekar Srinivasa, Kuralayanapalya Puttahonnappa Suresh, Sharanagouda S. Patil, Bindya Shivananda, Shiva Prasad Kollur, Chandan Shivamallu
Format: Article
Language:English
Published: Oman Medical Specialty Board 2022-09-01
Series:Oman Medical Journal
Subjects:
non-small cell lung cancer
meta-analysis
docetaxel
india
Online Access:https://omjournal.org/articleDetails.aspx?coType=1&aId=3249

Internet

https://omjournal.org/articleDetails.aspx?coType=1&aId=3249

Similar Items